Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year | Award Type | Project # | RFA # | PI/Project Leader | Institution | Title | Status |
---|---|---|---|---|---|---|---|
2022 | R21 | CA258008 | CA21-003 | SCARCELLI, GIULIANO | UNIV OF MARYLAND, COLLEGE PARK | Stimulated Brillouin Flow Cytometry for biomechanical assessment of metastatic potential | Active |
2021 | R21 | CA247647 | RFA-CA-20-017 | WILSON, GERALD M | UNIVERSITY OF MARYLAND BALTIMORE | Suppressing oncogenic RNA regulons using engineered zinc finger ribonucleases | Active |
2022 | R33 | CA267219 | RFA-CA-21-004 | LANDAU, DAN | WEILL MEDICAL COLL OF CORNELL UNIV | Expanding the GoT toolkit to link single-cell clonal genotypes with protein, transcriptomic, epigenomic and spatial phenotypes | Active |
2022 | R33 | CA267221 | CA21-004 | NORMAN, THOMAS MAXWELL | SLOAN-KETTERING INST CAN RESEARCH | Systematic characterization of cancer variants using single-cell functional genomics | Active |
2021 | R21 | CA250597 | RFA-CA-20-017 | ZHANG, FANGLIANG | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE | Targeted degradation of proteins by affinity peptide conjugated ubiquitin (APCU) | Active |
2023 | R61 | CA278558 | RFA-CA-22-001 | YAN, HAO | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | High-throughput, purification-free, and ultrasensitive transmembrane nanosensor arrays for digital counting of microRNA biomarkers of intact exosomes | Active |
2022 | R21 | CA267222 | CA21-003 | LEE, HAKHO | MASSACHUSETTS GENERAL HOSPITAL | 3D Fourier Imaging System for High Throughput Analyses of Cancer Organoids | Active |
2021 | R21 | CA251015 | RFA-CA-20-017 | STILL, AMANDA NICOLE HAYMOND | GEORGE MASON UNIVERSITY | New Hybrid Molecular Modalities Comprised of DNA-Origami and Interfering Peptides as Inhibitors of Protein-Protein Interactions | Active |
2022 | R21 | CA272326 | RFA-CA-21-003 | KELLY, RYAN T | BRIGHAM YOUNG UNIVERSITY | In-depth and label-free proteome profiling of hundreds of single cells per day | Active |
2022 | R21 | CA257980 | CA21-003 | BELCHER, ANGELA M | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | A cell-cycle induced genetic recorder for simultaneous recovery of cell divisions and lineage | Active |
2021 | R21 | CA255894 | RFA-CA-20-017 | XIAO, HAN | RICE UNIVERSITY | Development of Bone-Targeting Antibodies for Ewing Sarcoma Using Genetic Code Expansion | Active |
2023 | R61 | CA281657 | RFA-CA-22-001 | LUKER, GARY D | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Integrated Imaging Tools for Intercellular Chemokine Signalling | Active |
2022 | R33 | CA267226 | CA21-004 | DRAKE, RICHARD R | MEDICAL UNIVERSITY OF SOUTH CAROLINA | Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids | Active |
2021 | R21 | CA256081 | RFA-CA-20-017 | SWAGER, TIMOTHY M | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Innovative Droplet Lenses for NextGen Light Sensors of Biomarkers of Inflammation | Active |
2020 | R33 | CA240191 | RFA-CA-19-020 | RECHT, MICHAEL | PALO ALTO RESEARCH CENTER | High-Throughput Screening Platform for Cancer Drug Discovery | Active |
2023 | R61 | CA278402 | RFA-CA-22-001 | BRAVO CORDERO, JOSE JAVIER | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | Intersectional genetics-based biosensors for dormant cancer cells | Active |
2022 | R21 | CA267260 | CA21-003 | ARMITAGE, BRUCE A | CARNEGIE-MELLON UNIVERSITY | Fluorescent gammaPNA Miniprobes for Imaging Telomeric RNA | Active |
2021 | R21 | CA256082 | RFA-CA-20-017 | BAR-PELED, LIRON | MASSACHUSETTS GENERAL HOSPITAL | Chemical Proteomic Identification of Druggable Oncogenic Transcription Factors | Active |
2023 | R33 | CA281875 | RFA-CA-22-004 | BRUDNO, YEVGENY | NORTH CAROLINA STATE UNIVERSITY RALEIGH | MASTER Scaffolds for Rapid, Single-Step Manufacture and Prototyping of CAR-T cells | Active |
2022 | R21 | CA257816 | CA21-003 | COUNTER, CHRISTOPHER M | DUKE UNIVERSITY | Adapting K-MDS to detect KRAS-mutant ctDNA | Active |
2021 | R21 | CA258019 | RFA-CA-20-017 | CHEN, KAI | UNIVERSITY OF SOUTHERN CALIFORNIA | Novel Bisphosphonate PET Probes for Myeloma Bone Disease | Active |
2023 | R33 | CA278392 | RFA-CA-22-002 | KLEIN, ALLON MOSHE | HARVARD MEDICAL SCHOOL | Micro-capsules for versatile multiplexed cytometry | Active |
2022 | R33 | CA261696 | CA21-004 | MERAJVER, SOFIA DIANA | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence | Active |
2021 | R33 | CA247700 | RFA-CA-20-018 | JI, HANLEE P | STANFORD UNIVERSITY | Multimodal iterative sequencing of cancer genomes and single tumor cells | Active |
2022 | R33 | CA267258 | RFA-CA-21-004 | LEE, ABRAHAM P | UNIVERSITY OF CALIFORNIA-IRVINE | Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy | Active |
2022 | R33 | CA269015 | CA21-004 | ADEY, ANDREW | OREGON HEALTH & SCIENCE UNIVERSITY | Accessible high-throughput single-cell genome sequencing | Active |
2021 | R33 | CA247744 | RFA-CA-20-018 | GARTNER, ZEV JORDAN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | Universal Sample Multiplexing for Single Cell Analysis | Active |
2023 | R61 | CA278531 | RFA-CA-22-001 | SHIRURE, VENKTESH | UNIVERSITY OF CALIFORNIA AT DAVIS | Microfluidic technology to isolate tumoricidal T-cells from peripheral blood | Active |
2022 | R33 | CA258012 | CA21-004 | KARGINOV, ANDREI V | UNIVERSITY OF ILLINOIS AT CHICAGO | Optogenetic Control of Tumor Initiation and Tumor Progression in vivo | Active |
2021 | R33 | CA251006 | RFA-CA-20-020 | HAUN, JERED BRACKSTON | UNIVERSITY OF CALIFORNIA-IRVINE | Microfluidic tumor tissue processing platform for single cell diagnostics | Active |
2022 | R21 | CA269099 | RFA-CA-21-003 | YAKOVLEV, VLADISLAV V | TEXAS ENGINEERING EXPERIMENT STATION | Molecular and cellular imaging of bone biopsies using AI augmented deep UV Raman microscopy | Active |
2022 | R21 | CA269091 | CA21-005 | BORGES, CHAD R | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions | Active |
2021 | R33 | CA255893 | RFA-CA-20-018 | SEELIG, GEORG | UNIVERSITY OF WASHINGTON | Joint receptor and protein expression immunophenotyping through split-pool barcoding | Active |
2022 | R21 | CA272351 | RFA-CA-21-003 | SOPER, STEVEN ALLAN | UNIVERSITY OF KANSAS LAWRENCE | Molecular Sub-typing Breast Cancer Patients using a Liquid Biopsy | Active |
2022 | R33 | CA269094 | CA21-004 | MOELLERING, RAYMOND E | UNIVERSITY OF CHICAGO | Single-Cell Protein Activity Profiling in Breast Cancer Cells and Tissues | Active |
2021 | R33 | CA256102 | RFA-CA-20-018 | GREENBERG, JOEL | DUKE UNIVERSITY | Multimodality X-ray transmission and diffraction scanner for molecular analysis of cancer specimens | Active |
2023 | R33 | CA281802 | RFA-CA-22-002 | LABAER, JOSHUA | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck | Active |
2022 | R21 | CA261775 | CA21-003 | LIN, QIAO | COLUMBIA UNIV NEW YORK MORNINGSIDE | A Practical Approach to Tumor-Specific Aptamers for B-Cell Hematologic Malignancies | Active |
2021 | R33 | CA257878 | RFA-CA-20-018 | HANSEN, ANDERS SEJR | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Super-resolution microscopy for dynamic analysis of focal enhancer amplifications in cancer | Active |
2020 | R21 | CA240220 | RFA-CA-19-019 | ALEXANDRAKIS, GEORGIOS | UNIVERSITY OF TEXAS ARLINGTON | Nanotechnology Enabled Selection Of MHC-peptide Ligands To Personalize Cancer Therapy | Active |
2022 | R21 | CA267245 | RFA-CA-21-005 | SHIBATA, DARRYL K | UNIVERSITY OF SOUTHERN CALIFORNIA | Photolithographic Tumor DNA Isolation | Active |
2022 | R33 | CA269100 | CA21-004 | CHIU, BRIAN C-H | UNIVERSITY OF CHICAGO | A highly sensitive linear amplification based DNA methylation profiling technique for clinical cancer research | Active |
2021 | R33 | CA258016 | RFA-CA-20-018 | LIU, XUEFENG | OHIO STATE UNIVERSITY | Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics | Active |
2001 | R21 | CA092792 | PAR-99-102 | ZHOU, PENGBO | WEILL MEDICAL COLLEGE OF CORNELL UNIV | PROTEIN KNOCKOUT TECHNOLOGY/MOLECULAR ANALYSIS OF CANCER | Complete |
2003 | R33 | CA101136 | PAR-01-106 | FURGE, KYLE A | VAN ANDEL RESEARCH INSTITUTE | COMPARATIVE GENOMIC ANALYSIS OF MICROARRAY DATA | Complete |
2007 | R21 | CA126700 | RFA-CA-07-001 | DING, ZHIYONG | UT MD ANDERSON CANCER CTR | EFFECTIVE MAMMALIAN TWO HYBRID SCREENING APPROACH | Complete |
2009 | R33 | CA137673 | RFA-CA-08-008 | BEEBE, DAVID J | UNIVERSITY OF WISCONSIN-MADISON | MICROCHANNEL CELL-BASED ASSAYS TO ENABLE CANCER RESEARCH | Complete |
2013 | R33 | CA177461 | RFA-CA-12-003 | FURDUI, CRISTINA MARIA | WAKE FOREST UNIVERSITY HEALTH SCIENCES | NEW REAGENTS FOR TRACKING PROTEIN OXIDATION IN CELLS BY MS AND IMAGING METHODS | Complete |
2016 | R43 | CA203647 | PAR-13-327 | LIM, MARK | AMBERGEN, INC | Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays | Complete |
2000 | R33 | CA088347 | PAR-99-102 | POOLA, INDIRA NONE | HOWARD UNIVERSITY | MOLECULAR ASSAY FOR ESTROGEN RECEPTORS IN BREAST TUMORS | Complete |